[1]
Mora Román, J.J., Arias Sancho, S., Moncada Corrales, J., Quesada Salazar, C., Sánchez Romero, M.F. and Venegas Córdoba, P. 2019. Tyrosine kinase inhibitors employed for the treatment of chronic myeloid leukemia: Current and future. Revista Médica de la Universidad de Costa Rica. 13, 2 (Oct. 2019), 44–60. DOI:https://doi.org/10.15517/rmucr.v13i2.39618.